Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Keshuai Dong"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-19 (2023)
Abstract Hepatocellular carcinoma (HCC) is a highly heterogeneous cancer, and more effective prognostic markers are needed. Lactic acid has been proved to be an important metabolite involved in cancer development, metastasis, and the tumor microenvir
Externí odkaz:
https://doaj.org/article/2763fee476c944ee825834ae97e0a8de
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundImmune checkpoint inhibitors (ICIs) represent a paradigm shift in the development of cancer therapy. However, the improved efficacy of ICIs remains to be further investigated. We conducted a systematic review and meta-analysis to evaluate t
Externí odkaz:
https://doaj.org/article/eecadfaf21a04d8284084219d2763c90
Autor:
Xin Zhang, Hongwei Zhang, Zhibin Liao, Jiacheng Zhang, Huifang Liang, Weixing Wang, Jia Yu, Keshuai Dong
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background The Src homology and collagen 4 (SHC4) is an important intracellular adaptor protein that has been shown to play a pro-cancer role in melanoma and glioma. However, the biological function and detailed mechanisms of SHC4 in hepatoc
Externí odkaz:
https://doaj.org/article/6d1146f4083a42eda7a44db26dd2df4a
Autor:
Lilong Zhang, Chen Chen, Dongqi Chai, Chunlei Li, Tianrui Kuang, Li Liu, Keshuai Dong, Wenhong Deng, Weixing Wang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: Immune checkpoint inhibitors (ICIs) have recently demonstrated promising performance in improving the prognosis of urological cancer patients. The goal of this meta-analysis was to determine the impact of PPI use on the clinical outcomes o
Externí odkaz:
https://doaj.org/article/f6f19762c98a40f0856e949151376118
Autor:
Lilong Zhang, Dongqi Chai, Chen Chen, Chunlei Li, Zhendong Qiu, Tianrui Kuang, Mungur Parveena, Keshuai Dong, Jia Yu, Wenhong Deng, Weixing Wang
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Numerous studies have demonstrated the importance of gut bacteria in the development of malignancy, while relatively little research has been done on gut mycobiota. As a part of the gut microbiome, the percentage of gut mycobiota is negligible compar
Externí odkaz:
https://doaj.org/article/05d3088b02e940b4a597d2180b7e9ce8
Autor:
Wan Fu, Guangcai Yu, Junnan Liang, Pan Fan, Keshuai Dong, Bixiang Zhang, Xiaoping Chen, Hong Zhu, Liang Chu
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Accumulating evidences indicate that non-coding RNAs play crucial roles in the progression of an extensive range of carcinomas. This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-1
Externí odkaz:
https://doaj.org/article/7c8be459d0114d5a8b8ee94174b97cb8
Autor:
Xin Zhang, Keshuai Dong, Jiacheng Zhang, Tianrui Kuang, Yiyun Luo, Jia Yu, Jinming Yu, Weixing Wang
Publikováno v:
Cancer Science. 114:2001-2013
Autor:
Liuliu Zi, Wangbin Ma, Lilong Zhang, Boyang Qiao, Zhendong Qiu, Junhui Xu, Jiacheng Zhang, Yahong Ye, Yueyuan Yang, Keshuai Dong, Chen Chen, Weixing Wang, Qingyan Zhao
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 10; Pages: 3552
Uridine is a key metabolite used as a substrate for the production of DNA, RNA, and glucose, and it is mainly synthesized in the liver. Currently, it is not known whether uridine levels are altered in the tumor microenvironment of patients with hepat
Autor:
Xiaochao Zhang, Yabing Hu, Yonglong Pan, Yixiao Xiong, Yuxin Zhang, Mengzhen Han, Keshuai Dong, Jia Song, Huifang Liang, Zeyang Ding, Xuewu Zhang, He Zhu, Qiumeng Liu, Xun Lu, Yongdong Feng, Xiaoping Chen, Zhanguo Zhang, Bixiang Zhang
Publikováno v:
Oncogene. 41:1821-1834
Discoidin domain receptor 1 (DDR1) is a member of the receptor tyrosine kinase family, and its ligand is collagen. Previous studies demonstrated that DDR1 is highly expressed in many tumors. However, its role in hepatocellular carcinoma (HCC) remains
Autor:
Lilong Zhang, Jiarui Feng, Tianrui Kuang, Dongqi Chai, Zhendong Qiu, Wenhong Deng, Keshuai Dong, Kailiang Zhao, Weixing Wang
Publikováno v:
International Immunopharmacology. 118:110019